Literature DB >> 27453295

How can postoperative delirium be predicted in advance? A secondary analysis comparing three methods of early assessment in elderly patients.

Sebastian Stukenberg1, Martin Franck, Claudia D Spies, Bruno Neuner, Isaac Myers, Finn M Radtke.   

Abstract

BACKGROUND: Postoperative impairment of the cerebral function can appear immediately after general anesthesia and may be predictive for a postoperative delirium. We compared three tools assessing patients on recovery room admission in order to detect early signs of postoperative brain dysfunction: the Postanesthetic Recovery Score (PARS), the Richmond Agitation-Sedation Scale (RASS) and the Nursing Delirium Screening Scale (Nu-DESC).
METHODS: Inclusion criteria of this secondary analysis of the randomized SuDoCo trial were: age ≥60 years, schedule for elective non-cardiac surgery with an anticipated duration of ≥60 minutes, general anesthesia, ability to communicate in German language. A total of 996 patients were analyzed. Investigated scores were assessed 10 minutes after recovery room admission and analyzed in terms of association with postoperative delirium, mortality and length of stay in the recovery room. Multivariate analysis: linear or logistic regression.
RESULTS: Abnormal scores in patients: RASS (values ≤-2 and ≥1) 36.8%, Nu-DESC (≥2 points) 54.2%, PARS (≤7 points) 20.3%. Abnormal RASS values were associated with postoperative delirium (RASS values ≥1: odds ratio (OR) 3.1, 95% CI: 1.7-5.6, P<0.001; RASS values ≤-2: OR=2.1, 95% CI: 1.3-3.3, P=0.001). Abnormal Nu-DESC values were also associated with postoperative delirium (OR=2.4, 95% CI: 1.5-3.9, P<0.001). Abnormal PARS values were associated with a longer recovery room stay (in minutes, OR=16.6, 95% CI: 1.7-31.4, P=0.029).
CONCLUSIONS: The RASS and Nu-DESC were independent predictors for a delirium within seven postoperative days. Very early assessment of the cerebral function may help to advance detection, prevention and treatment of postoperative delirium in elderly patients.

Entities:  

Mesh:

Year:  2016        PMID: 27453295

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  6 in total

Review 1.  Delirium screening tools in the post-anaesthetic care unit: a systematic review and meta-analysis.

Authors:  Rami K Aldwikat; Elizabeth Manias; Emily Tomlinson; Mohammed Amin; Patricia Nicholson
Journal:  Aging Clin Exp Res       Date:  2022-01-03       Impact factor: 3.636

2.  Effect of sedative premedication with oral midazolam on postanesthesia care unit delirium in older adults: a secondary analysis following an uncontrolled before-after design.

Authors:  Karin Stuff; Elena Kainz; Ursula Kahl; Hans Pinnschmidt; Stefanie Beck; Franziska von Breunig; Rainer Nitzschke; Sandra Funcke; Christian Zöllner; Marlene Fischer
Journal:  Perioper Med (Lond)       Date:  2022-05-19

3.  Hypertonic saline for prevention of delirium in geriatric patients who underwent hip surgery.

Authors:  Xi Xin; Fei Xin; Xuguang Chen; Qi Zhang; Yanan Li; Shuping Huo; Chongfu Chang; Qiujun Wang
Journal:  J Neuroinflammation       Date:  2017-11-14       Impact factor: 8.322

4.  ICU Delirium-Prediction Models: A Systematic Review.

Authors:  Matthew M Ruppert; Jessica Lipori; Sandip Patel; Elizabeth Ingersent; Julie Cupka; Tezcan Ozrazgat-Baslanti; Tyler Loftus; Parisa Rashidi; Azra Bihorac
Journal:  Crit Care Explor       Date:  2020-12-16

5.  The Potential Role of Lung-Protective Ventilation in Preventing Postoperative Delirium in Elderly Patients Undergoing Prone Spinal Surgery: A Preliminary Study.

Authors:  Jing Wang; Lian Zhu; Yanan Li; Chunping Yin; Zhiyong Hou; Qiujun Wang
Journal:  Med Sci Monit       Date:  2020-10-04

6.  Implementation of strategies to prevent and treat postoperative delirium in the post-anesthesia caring unit : A German survey of current practice.

Authors:  Thomas Saller; Klaus F Hofmann-Kiefer; Isabel Saller; Bernhard Zwissler; Vera von Dossow
Journal:  J Clin Monit Comput       Date:  2020-05-09       Impact factor: 2.502

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.